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Background: Mind–body exercises (MBEs) have been widely accepted as a
complementary therapy for the patients with low exercise tolerance. Currently, the
number of experimental studies investigating the effect of MBEs for improving
symptoms in people with schizophrenia is increasing. However, results are inconsistent.
Methods: We systematically reviewed and meta-analyzed the effects of mind–body
exercises on schizophrenia. Seven electronic databases (Pubmed, Web of Science,
PsycINFO, Embase, Cochrane Central Register of Controlled Trials [CENTRAL], CNKI
andWangfang) were screened through October 2019 and risks of bias of included studies
were assessed in Review Manager 5.3.
Results: Meta-analysis on 13 studies with 1,159 patients showed moderately significant
effects in favor of mind–body exercise intervention to improve positive symptoms (SMD =
0.31; 95% CI 0.01 to 0.60; p = 0.04), negative symptoms (SMD = 0.37; 95% CI 0.14 to
0.60; p = 0.002), and depression (SMD = 0.88; 95% CI 0.63 to 1.13; p<0.00001). Meta-
regression analysis revealed that the improvement in positive symptoms was positively
associated with the frequency of intervention (p = 0.04), while a marginally significant
correlation was observed between the improved negative symptoms and duration of each
session (p = 0.06).
Conclusions: This meta-analysis supports the therapeutic effects of MBEs to aid in the
treatment of schizophrenia. Further studies need to incorporate rigorous design and large
sample size to identify the optimal type and dose of mind–body exercise to inform clinical
practices on MBEs’ recommendations for the management of schizophrenia symptoms.
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INTRODUCTION
Schizophrenia, as one of the chronic and severe mental illness,
usually emerges between 16 and 30 years old, with its prevalence
ranging from 0.33 to 0.75% globally (1). There are three types of
symptoms that may be present in people with schizophrenia,
including positive symptoms (delusions and hallucinations),
negative symptoms (insufficient motivation, spontaneous
reduction of speech, and social withdrawal), and cognitive
symptoms (executive dysfunction, inattention, and working
memory impairment) (2). These complex symptoms may also
lead to a decline in social function and quality of life, a high
degree of disability, and concurrent emotional diseases. It has
become a public health issue because of its profound impact on
family and society (3).
Since its pathology still remains elusive, treatments primarily
focus on alleviating symptoms of the disease and include
antipsychotic medications, psychosocial counseling, and
coordinated specialty care (4). Although antipsychotic drugs
can effectively improve certain positive symptoms, their
beneficial effects on negative symptoms are limited (3, 5–8),
and around 30% of patients are refractory to treatment (9).
Moreover, antipsychotic drugs are connected with side effects
including hesitation, retention, and transient leukopenia (10, 11).
Prolonged use of antipsychotics may exacerbate the progression
of cognitive impairment caused by schizophrenia (10, 11) and
even lead to more adverse effects, which has been associated with
impairments of the endocrine system (weight gain,
hyperprolactinemia, and diabetes mellitus), the cardiovascular
system (orthostatic hypotension), and the central nervous system
(dystonia, akathisia, pseudoparkinsonism, and dyskinesia) (11).
Psychosocial counseling and coordinated specialty care are
typically adopted as a second line of treatment when
antipsychotic medications fail to alleviate symptoms. These
methods are expert-based and require a significant amount of
time and cost heavily. Thus, researchers have attempted to seek
low risk alternative therapies for people with schizophrenia.
Tai Chi, Yoga, and Qigong (including Baduanjin and Wuqinxi)
are the three most popular mild to moderate intensity mind–body
exercises (MBEs), and they have been increasingly accepted for
treating patients with low exercise tolerance (12–18). MBEs are
characterized by slow physical movement (stretching and relaxation
of skeletal muscles) coordinated with abdominal breathing and
meditative stage of mind (19, 20). These unique features have
intrigued researchers and clinicians to extensively investigate the
therapeutic effects of MBEs on diseases, particularly for those who
are diagnosed with mental illnesses like schizophrenia (21). Indeed,
the number of studies reporting beneficial effects of MBEs in
schizophrenia is growing. However, findings are inconsistent:
some studies showed that MBEs could be a useful add-on
treatment for schizophrenia (22, 23), while others did not believe
MBEs could offer more advantages over regular exercise or
treatment as usual (24). Thus, a systematic review is needed to
synthesize the existing literature. While there were five reviews on
this topic, they focused on either one type ofMBE (25), just negative
symptoms (26, 27), qualitative synthesis (26) or MBEs-active
control comparison (28), or included non-MBE studies (26),
which make it difficult to provide an overview of MBE-induced
effect on multiple symptoms of schizophrenia. Therefore, a
comprehensive review with quantitative synthesis is necessary to
systematically investigate the association between MBEs and a wide
range of health outcomes in schizophrenia. Findings of this meta-
analysis can identify knowledge gaps and provide researchers and
clinicians with evidence-based recommendations so as to develop
effective MBE treatments for schizophrenia patients.
METHODS
This study followed PRISMA guidelines (29) and Cochrane
Collaboration’s recommendation (30) for systematic reviews
and meta-analyses.
Search Strategies
Five English databases (PubMed, Web of Science, PsycINFO,
Embase, Cochrane Central Register of Controlled Trials
(CENTRAL)) and two Chinese databases (CNKI, Wangfang)
were systematically searched from their inception to October 1st
2019. Literature search was detailed below:(((schizophrenia
[Title/Abstract]) OR schizophrenic [Title/Abstract])) AND
((((((((((((mind–body[Title/Abstract]) OR mind body [Title/
Abstract]) OR meditation[Title/Abstract]) OR meditative[Title/
Abstract]) OR Tai Chi[Title/Abstract]) OR Taiji[Title/Abstract])
OR Qigong[Title/Abstract]) OR Baduanjin[Title/Abstract]) OR
Wuqinxi[Title/Abstract]) OR Yoga[Title/Abstract]) OR Yogic
[Title/Abstract]) OR Pilates[Title/Abstract]). Reference lists of
identified studies were also screened.
Eligibility Criteria
Firstly, studies (including randomized controlled trials and
controlled trials with non-randomization) published in English
and Chinese were considered eligible only if full-text articles
could be retrieved. Secondly, subjects had to be aged 16 and
above who were diagnosed with schizophrenia. Thirdly, to be
eligible, the experimental group must involve at least one type of
MBE (e.g., Tai Chi, Qigong, or Yoga) alone or a combined
training mode, whereas participants in the control group
maintained their unaltered lifestyle or engaged in an active
control condition like psychotherapy. Initially identified
records were screened by two independent reviewers to remove
duplicates and obviously irrelevant records. Then, potentially
eligible full-text articles were read to determine if they met the
eligibility criteria or not. Disagreements were discussed with a
third reviewer author.
Data Extraction and Management
Two reviewers used a priori developed data extraction forms to
record all the information and extract data on patients
independently in demographic data, methods, interventions,
protocol as well as the outcomes.
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Risk of Bias in Individual Studies
Risk of bias of eligible studies was assessed in Review Manager
5.3 software and the criteria of Cochrane Handbook for
Systematic Reviews and meta-analysis were followed (30). The
quality of evidences were also assessed via GRADE (Grading of
Recommendations Assessment, Development and Evaluation)
system (31).
Data Analysis
Assessment of Effect Size
Review Manager software was used for meta-analyses in
random-effects model (30). Meta-analysis was only conducted
if there were two or more pairs (experimental group vs control
group) of comparisons on at least one health outcome (30).
Standardized mean differences (SMD) with 95% confidence
intervals (CI) were calculated as the difference in means
between groups divided by the pooled standard deviation.
SMD that reflects the magnitude of the overall effect size was
categorized into: 1) Small = 0.2 to 0.5; 2) moderate = 0.5 to 0.8
and 3) large = 0.8 and above (32).
Levels of evidence were classified into five levels (strong
evidence, moderate evidence, limited evidence, conflicting
evidence, and no evidence) based on consistent findings,
number of RCTs and risk of bias (33).
Assessment of Heterogeneity
I² statistic was used to identify between-study heterogeneity (low
heterogeneity = 0–25%, moderate heterogeneity = 26–50%,
substantial heterogeneity = 51–75%, and considerable
heterogeneity = 76–100%) (30, 34).
Meta-Regression
Weighted meta-regressions were conducted for continuous,
moderator variables like total duration of intervention,
frequency of intervention, and duration of each session (35).
RESULTS
Literature Search
As Figure 1 showed, the literature search retrieved 308 records in
total, and 118 records were excluded for duplication. Then, 190
records were screened by title and abstract, and 125 records were
excluded for relevancy. Sixty-five full-text articles were screened,
and 52 records were excluded with reasons (two included non-
schizophrenia patients, two did not use MBEs in the
experimental group, 17 did not remain unaltered lifestyle or
engage in active control condition like psychotherapy in the
control group, 26 without relevant outcomes, two non-controlled
FIGURE 1 | The Detailed Process of Study Selection.
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experiments, two reviews and one non-original publication).
Finally, 13 studies with 1,159 patients were included in this
systematic review and meta-analysis (22–24, 36–45).
Study Characteristics
This systematic review and meta-analysis included 13 studies (11
randomized controlled studies (22–24, 36, 38–42, 44, 45), one
non-randomized controlled study (37) and one quasi-
experimental study (43). Characteristics of the participants,
interventions, and outcome assessments are shown in Table 1.
Setting and Participant Characteristics
Among the 13 studies that were included, six originated from
India (559 participants), three from China (376 participants),
two from Japan (106 participants), one from Turkey (100
participants) and one from America (18 participants). Patients
were recruited from hospitals, rehabilitation residencies, a
community health center, and mental health centers.
Patients in five studies were diagnosed with schizophrenia
according to DSM-IV, two with DSM-IV-TR, one with
Diagnostic Interview for Genetic Studies (DIGS), and two with
ICD-10. Two studies did not report the diagnostic criteria.
Patients in one study were diagnosed with psychiatric
disorders according to ICD-10. In the study of Bhatia et al.,
physical and mental comorbidities were: bipolar I disorder (n =
40), major depression disorder (n = 37) and cardiology (n = 68).
Patients’mean age ranged from 18 to 65 years. All trials included
both males and female.
Risk of Bias Within Studies
Figure 2 summarizes the risk of bias in the selected studies. It
shows that the selected studies demonstrated low risk of bias
except blinding of participants and personnel for its unfeasibility
for conducting MBEs’ interventional study. Specifically, 11
studies were RCTs and used adequate random sequence
generation. Only one study stated that assessors were not
blinded, and one study had attrition bias (incomplete outcome
data). Six studies had allocation concealment procedures.
Three studies had been affected by reporting bias, and four had
other potential sources of bias. Additionally, according to
the assessment through GRADE system, five of 10 outcomes
(positive and negative symptoms, depression, general
psychopathology, and social function) were of moderate
quality, while the others were of low quality (Table 2).
Outcomes
Mind–Body Exercises vs. Treatment as Usual
Nine studies with data on the effects of MBEs on positive symptoms
were entered into the model 1 (22–24, 36, 39–42, 45). A sensitivity
analysis was performed to determine consistency of the effects of
MBEs on positive symptoms. By checking both the visually
asymmetrical Funnel Plot (Figure 3) and the Egger’s Regression
Test (Egger’s regression intercept = 2.70, p = 0.17), two studies were
removed (SMD = 0.34) (24, 42). After their removal, the funnel plot
of the remaining studies showed a symmetrical Funnel plot (Egger’s
regression intercept = 1.43, p = 0.56).
For the meta-analysis in the remaining seven studies,
compared with the control group, the aggregated results
showed a significant benefit in favor of MBEs on positive
symptoms (SMD = 0.29; 95% CI 0.03 to 0.55; I² = 36%; p =
0.03; Figure 3).
Nine studies with data on the effects of MBEs on negative
symptoms were entered into the model 1 (22–24, 36, 39–42, 45).
A sensitivity analysis was performed to determine consistency of
the effects of MBEs on negative symptoms. By checking both the
visually asymmetrical Funnel Plot (Figure 3) and the Egger’s
Regression Test (Egger’s regression intercept = 0.26, p = 0.88),
one study was then removed (SMD = −0.19) (41). After that, the
remaining eight studies showed a symmetrical Funnel plot
(Egger’s regression intercept = 0.88, p = 0.58). Meta-analysis
showed that compared with the control group, the aggregated
results showed a benefit in favor of MBEs on negative symptoms
(SMD = 0.43; 95% CI 0.20 to 0.65; I² = 46%; p = 0.0002;
Figure 3).
Four studies with data on the effects of MBEs on depression
were entered into the model 2 (22, 24, 36, 40). Compared with
the control group, the aggregated results showed a significant
benefit in favor of MBEs on depression (SMD = 0.88; 95% CI
0.63 to 1.13; I² = 0%; P <0.00001; Figure 3).
Compared with usual treatment, there were moderately
significant effects in favor of MBE intervention on improving
anergia (p<0.0001) and side effects (p = 0.007). However, no
significant effects were found on general psychopathology (p =
0.18), social function (p = 0.18), cognition (p = 0.20), quality of
life (physical score: p = 0.16), (psychological score: p = 0.16),
(social score: p = 0.23), (environment score: p = 0.37), and
extrapyramidal symptoms (p = 0.13).
Meta-Regression
For both positive and negative symptoms, multiple separate
meta-regressions were performed for total minutes, weekly
frequency, and MBE session length. Results showed that
weekly frequency was significantly correlated with improved
positive symptoms (p = 0.04; Figure 4). Notably, session
length was marginally correlated with improved negative
symptoms (p = 0.06; Figure 4). All results of meta-regression
are presented in Figure 4.
DISCUSSION
This meta-analysis systematically evaluated emerging evidence
regarding the effects of MBEs on multiple health outcomes for
individuals with schizophrenia. Results of the current review
indicate that MBEs (primarily including Tai Chi and Yoga) may
have beneficial effects for improving disease-specific outcomes
(positive symptom, negative symptom and depression). Such
promising results suggest that MBEs could be an effective
complementary therapy for symptomatic management of
Wei et al. Mind–Body Exercises on Schizophrenia
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TABLE 1 | Descriptive Information of Included Studies.
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schizophrenia. More specifically, weekly frequency has shown to
be positively associated with improved positive symptoms, while
session length is marginally associated with negative symptoms
with non-significant level. Notably, findings of this meta-analytic
paper appear to be consistent with two previous reviews on
negative symptoms (26, 28), but not positive symptoms.
In the early literature, MBEs are defined as mild to moderate-
intensity of exercise modality where practitioners need to
perform physical movement at slow pace while integrated with
mental focus and relaxation, meditative state of mind, and deep
abdominal breathing (46). Such nature of MBEs has been
extensively investigated, suggesting that these unique exercise
modalities have beneficial effects for mood regulation in healthy
populations and treating disease-specific outcomes among
individuals with psychiatric disorders, especially negative
emotion (e.g., anxiety and depression). Therefore, it seems to
be reasonable to observe improved negative symptoms of
schizophrenia in this systematic review.
Prefrontal and temporal cortex abnormalities have been
shown to be connected with symptoms (negative emotion,
inattention, dysfunction in cognition) of schizophrenic patients
(47–49). Biological mechanism remains largely unknown about
how MBEs affect symptoms of schizophrenia. Some researchers
proposed that these positive results may be attributed to Tai Chi-
induced change in brain intrinsic cortical structure and function
(50, 51). Early imaging studies by Wei et al. (50) indicated that
Tai Chi training was associated with increased cortical thickness
in brain regions related to executive functions (50), as well as
decreased functional homogeneity in dorsolateral prefrontal
cortex that potentially optimizes locally functional organization
(51). Such Tai Chi-induced change in the prefrontal lobes of the
elderly may be a possible explanation for the observed positive
effects for symptoms of schizophrenia in the current review.
Additionally, as mentioned previously, meditative stage of mind
as an essential element of MBEs needs to be achieved while
performing physical movement in coordination with breathing
control and mental focus. Meditation alone as an intervention
program has been extensively investigated, suggesting that it
could positively induce cortical change in the ACC, prefrontal
cortex, posterior cingulate cortex, and insula (52–57). These
areas were regarded as core regions for self-regulation of
attention (52, 53), emotion (54, 56), and awareness (55, 57).
Thus, it is plausible that the meditative component of MBEs
might play an important role to alleviate symptoms of
schizophrenia by improving brain structure and function.
Glucose metabolic abnormality was highly prevalent in patients
with schizophrenia. This abnormality is mainly processed by a
decrease in cerebral insulin receptors’ (b-subunit) expression (58),
signal transduction protein Akt1 activity (59) and insulin-
degrading enzyme neuronal expression (60). Different patterns of
regional glucose metabolism are related to different schizophrenia
syndromes: psychomotor poverty with left prefrontal and superior
parietal metabolic activity, reality distortion with left temporal
lobule, and disorganization with left inferior parietal lobule (61).
Recently, Huocheng et al. reported that aerobic exercise has
beneficial effects for improving glucose metabolism in the medial
frontal gyrus (MFG), which involves executive and visuospatial
attentional functions (62). A recent study found that one-year
aerobic exercise improved not only the glucose metabolism but also
psychiatric symptoms (63). Thus, MBEs as typical type of aerobic
exercise modalitiesmay have the potential to improve symptoms of
schizophrenia through regulating glucose metabolism.
Several limitations should be acknowledged while
interpreting our findings. Firstly, several included studies had a
small sample size with incomplete information, which limited
our capability to conduct subgroup analyses and more
comprehensive data exploration of moderators. Secondly,
MBEs were offered as adjunctive treatments of existing
interventions but not mono-therapy in most studies. It is
difficult to determine whether the positive result is due to
MBEs only, the synergistic intervention, or conventional
treatment received.
Implication
This study showed that MBEs are beneficial for schizophrenia as
an adjunctive treatment. These benefits can be seen in various
aspects of schizophrenia prognosis and exist throughout a
person’s life. In addition, MBE can also reduce the potential
risks of antipsychotics (i.e., hesitation, retention, and transient
FIGURE 2 | Risks of Bias within Studies.
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leukopenia) (10, 11), which are critical to the patients’ quality of
life and well-being. Therefore, a comprehensive intervention of
pharmacological and non-pharmacological treatment (i.e., MBE)
should be considered for patients with schizophrenia. In
addition, it is necessary for the therapists who teach MBEs to
receive training in mental health disorders to sensitize them to
the needs of patients. Psychiatrist should work closely with
therapists so that they can meet the needs of patients at any time.
TABLE 2 | Summary of findings via GRADE System.
Mind–Body Exercises Compared with Treatment as Usual for Schizophrenia
Patient or population: patients with schizophrenia.
Settings: home, community, or hospital.
Intervention: mind–body exercises.
Comparison: treatment as usual.










Assumed risk Corresponding risk
Treatment as Usual Mind–body Exercises
Positive
Symptoms
The mean score ranged across control
groups from
−0.60 to 4.50.
The mean score in the
intervention groups was





The mean score ranged across control
groups from −0.70 to 4.30.
The mean score in the
intervention groups was





The mean score ranged across control
groups from
−1.75 to 2.70.
The mean score in the
intervention groups was





The mean score ranged across control
groups from
−6.25 to 2.50.
The mean score in the
intervention groups was






The mean score ranged across control
groups from
−5.63 to 4.38.
The mean score in the
intervention groups was





The mean score ranged across control
groups from
−8.13 to 8.63.
The mean score in the
intervention groups was






The mean score ranged across control
groups from
−5.00 to 0.25.
The mean score in the
intervention groups was
4.82 (0.18 to 10.57).
/ 323 ⊕⊕⊝⊝
low
Social Function The mean score ranged across control
groups from
−1.48 to 3.54.
The mean score in the
intervention groups was
4.85 (2.74 to 7.57).
/ 289 ⊕⊕⊕⊝
moderate
Cognition The mean score ranged across control
groups from
−0.07 to 1.40.
The mean score in the
intervention groups was
1.39 (1.07 to 1.77).
/ 132 ⊕⊕⊝⊝
low
Depression The mean score ranged across control
groups from
−1.63 to 2.33.
The mean score in the
intervention groups was
2.71 (0.70 to 4.83).
/ 269 ⊕⊕⊕⊝
moderate
Anergia The mean score ranged across control
groups from
v2.00 to 1.03.
The mean score in the
intervention groups was
2.34 (1.13 to 3.20).
/ 109 ⊕⊕⊝⊝
low
Side Effects The mean score ranged across control
groups from
−0.20 to 0.10.
The mean score in the
intervention groups was





The mean score ranged across control
groups from
0.60 to 0.80.
The mean score in the
intervention groups was
0.20 (−0.10 to 0.50).
/ 106 ⊕⊕⊝⊝
low
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the
assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI, Confidence interval; RR, Risk Ratio; GRADE, Grading of Recommendations Assessment, Development and Evaluation.
GRADE Working Group grades of evidence.
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.
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FIGURE 3 | Forest Plot and Funnel Plot for Positive Symptoms, Negative Symptoms, and Depression.
FIGURE 4 | Meta-Regression of Intervention Factors for Improving Symptoms.
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CONCLUSIONS
This meta-analytic review of the existing literature suggests that
MBEs are effective interventions to improve symptoms of
schizophrenia. These findings provide safe and accessible
therapy to existing mainstream treatment (antipsychotic drugs
and psychotherapy), and clinicians should consider using MBEs
as complementary treatment for schizophrenia.
In the future, more strictly-designed RCTs with larger scale
are warranted to examine the therapeutic effects and potential
mechanism of MBEs for schizophrenia. Additionally, it is also
needed to explore how other types of MBEs (i.e., Tai Chi Chuan,
Qigong) influence the symptoms of schizophrenia so as to
advance the understanding of general benefits of the varied
forms of MBEs. Since impaired cognition is one of the main
symptoms for schizophrenia, researchers should investigate the
effect of MBEs on cognitive improvement of schizophrenia.
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